Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting injectable ART in adolescents and young adults with HIV
PACTR202402700796695Phase 3Unknown
- Sponsor
- Desmond Tutu Health Foundation
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 3, open-label trial in human immunodeficiency virus infection (HIV) (3 cohorts), sponsored by Desmond Tutu Health Foundation. Status: unknown.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202402700796695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402700796695.